Description

4basebio Plc operates as a biotechnology firm dedicated to the creation of advanced therapeutic medicinal products. Its strategy involves utilizing synthetic DNA and non-viral platforms specifically engineered for targeted nucleic acid delivery to cells. The company actively produces and supplies premium synthetic DNA suitable for diverse applications, including research, therapeutic interventions, and pharmacological uses. Moreover, 4basebio develops specialized non-viral vectors, designed to ensure the effective transportation of various therapeutic payloads within patients. This enterprise was established on December 22, 2020, and maintains its principal office in Cambridge, United Kingdom.